Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026

Distribution Agreement for Oncology Assays

By Labmedica staff writers
Posted on 22 Apr 2002
A global distribution agreement for oncology-related serum assays in microtiter plate ELISA format has been announced by Dako A/S (Glostrup, Denmark) and Bayer Diagnostics (Tarrytown, NY, USA). More...
The assays are designed to aid oncologists in the confirmation, monitoring, staging, screening, and prognosis of cancer.

Under the terms of the agreement, which is for five years, Bayer Diagnostics Oncogene Science Group is responsible for the manufacture and technical support of the product line, while Dako is responsible for worldwide sales, marketing, and customer support.
The assays include proprietary serum tests for the Her-2/neu oncoprotein, epidermal growth factor receptor (EGFr), urokinase plasminogen activator (uPA), plasminogen activator inhibitor-1 (PAI-1), and an assay that detects the complexes between uPA and PAI-1. Also included are separate tests for measuring the total and complexed forms of prostate-specific antigen (PSA) to aid in the detection of prostate cancer.

"This agreement puts an entirely new set of unique and important oncology research and disease management products in the hands of Dako's sales force,” said Jes Ostergaard, CEO of Dako, "and it underscores our commitment to bridging the diagnostic testing of oncology patients with their treatments.”





Related Links:
Bayer
Dako

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Glucose Meter
StatStrip®
New
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Reusable catheter patients used 35 percent fewer antibiotics compared to their single-use only counterparts. (Photo courtesy of the University of Southampton)

Reusable Intermittent Catheters Reduce Antibiotic Use Without Increasing Urinary Tract Infections

Intermittent self-catheterization, used to empty the bladder several times a day, can leave patients vulnerable to recurrent urinary tract infections and repeated antibiotic use. Reliance on single-use... Read more

Surgical Techniques

view channel
Image: Avvio Medical\'s technology combines microbubble-enhanced acoustic cavitation with smart catheter navigation to precisely target and break down ureteral stones, all without the need for routine stenting or general anesthesia (Photo courtesy of Avvio Medical)

Anesthesia-Sparing System Targets Faster Ureteral Stone Treatment

Ureteral stone care is often delayed by operating room scheduling constraints and growing wait times, leaving a gap between diagnosis and treatment. With no fundamentally new therapeutic approach introduced... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.